Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
設定
言語
日本
通貨
USD
テーマ
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
株式のランク #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
株価
$0.09933121
時価総額
$29.15K
変化（1日）
0.57%
変化（1年）
449.49%
国
IE
取引 Ovoca Bio plc (OVB)

カテゴリー

Healthcare
Ovoca Bio plc（OVB）の収益
Jun 2024 時点の収益 TTM: 0.00
Ovoca Bio plc の最新の財務報告によると、現在の収益 (TTM) は 0.00 です。2023 年には 0.00 の収益があり、これは 2022 年の 0.00 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Ovoca Bio plc の収益履歴（2001 ～ 2026）
各年末の収益
年 収益 変化
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
同業他社の収益
企業 収益 収益の差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $48.44B -
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.04B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.34B -
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $5.49B -
NL